JB Chemicals and Pharmaceuticals

JB Chemicals and Pharmaceuticals is a diversified, India-headquartered pharmaceutical company with leading positions in gastrointestinal, cardiovascular, anti-infective, and chronic care markets. Its marquee brands, including cilnidipine (Cilacar), ranitidine (Rantac), and metronidazole (Metrogyl), are top-ranked nationally. It operates an extensive pipeline of branded products, generics (including 16 US ANDA approvals and a US generics business), and proprietary products, and maintains robust financial performance with double-digit YoY growth in 2023-2025. The company has recently been acquired by Torrent Pharmaceuticals in a major consolidation move[8][3][1][6][2].